Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
about
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsTumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatmentOverview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.Multiple sclerosis reactivation postfingolimod cessation: is it IRIS?Aggressive multiple sclerosis: proposed definition and treatment algorithm.Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption.Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis.Fingolimod for the treatment of relapsing multiple sclerosis.Multiple sclerosis: basic knowledge and new insights in perioperative management.Disease modification in multiple sclerosis: an update.Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.Neurological safety of fingolimod: An updated reviewA comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placeboDisease reactivation after fingolimod discontinuation in two multiple sclerosis patients.Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis.Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study.[Current aspects of therapy conversion for multiple sclerosis].
P2860
Q26765300-4A4E60FB-7986-4731-A0B2-749A5689B706Q26777684-0001E995-D55D-4510-BC99-7A54AA888FC7Q30458371-642490BD-5325-4AD9-956C-815028FC11C4Q34365360-8AC439D9-089E-42BF-A80E-F8F4C2F8CD89Q34478828-0F28A60E-7AFE-4073-AAE1-23EE507069DFQ35659134-3A3CB042-E74A-4125-93F6-698FBC84081CQ35728024-E0627B0D-46EA-4F28-A7F1-E760C03EDE6EQ37615119-E97E3B47-026C-4D29-B4F4-3D9DA13EA226Q38112209-9C04662A-5483-4CCC-A2B4-F83E0AA1EB92Q38130445-B2EB330B-F0C5-4E20-B7DA-6D7C04C7ADACQ38150823-44EA8A25-60BF-4DEB-9039-812E6A0380A1Q38152451-068D7EE0-DFBB-4A56-9412-181B695CCBC3Q38163046-68AB52AE-98E7-42BA-A143-072FCF9C8225Q39278699-7F05E93B-5CA6-433A-B8C4-2A1ADE060D92Q39777527-3CFF5E46-767C-4DCB-B8AE-FC56FF9DD895Q41553443-2BE9432C-4B3C-4C98-9988-780F0CD043CEQ42287146-85B81757-994B-4DB2-8F72-2885176D0750Q44017725-3A5D2EA5-9BFC-4C5B-B78D-D6B6E5773BF9Q44735512-344C6D5D-8CFF-4046-88C9-0218A01F82B6Q47636264-9CB6F7DD-377B-46A7-BD6B-E581CF50C657Q48694924-E7B73E70-8566-4483-A9D5-5CE18E96D639Q50577133-858D9C1A-0B5E-4022-A9B5-7DADE131A04FQ53582374-23AA9702-D829-4661-9C1A-3A62E4C7A56B
P2860
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
@ast
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
@en
Rebound of disease activity after withdrawal of fingolimod
@nl
type
label
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
@ast
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
@en
Rebound of disease activity after withdrawal of fingolimod
@nl
prefLabel
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
@ast
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
@en
Rebound of disease activity after withdrawal of fingolimod
@nl
P2093
P1433
P1476
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
@en
P2093
Hannah L Pellkofer
Ingrid Meinl
Joachim B Havla
Lisa Ann Gerdes
Reinhard Hohlfeld
P304
P356
10.1001/ARCHNEUROL.2011.1057
P577
2012-02-01T00:00:00Z